JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.1763iti5
The Journal of Cell Biology, Vol. 176, No. 3, 245-
The Rockefeller University Press, 0021-9525 $30.00
© Leslie
This Article
Right arrow Full Text (PDF, 903K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Liberating TGFß



Figure 1
Only particular fibrillin-1 fragments activate TGFß signaling.

Overactive TGFß spurs Marfan's syndrome, which might have been responsible for Abraham Lincoln's rangy physique. But how the molecule gets released from storage and switched on is uncertain. On page 355 Chaudhry et al. fill in a key step, showing that a piece of an extracellular matrix (ECM) protein frees inert TGFß.

TGFß helps control whether cells move, divide, specialize, and survive. Cells often lock up the potent cytokine by fastening a complex containing its inactive form to fibrillin-1 fibers in the ECM. Discovering how this sequestered TGFß breaks loose might clarify the mechanism of Marfan's syndrome, in which fibrillin-1 mutations lead to symptoms such as a weakened aorta and leaky heart valves.

Chaudhry et al. demonstrated that fibrillin-1 itself helps release the TGFß complex. The researchers narrowed this ability to a small fragment of the protein. The segment doesn't bind to TGFß. Instead, it attaches tightly to the end of fibrillin-1 that carries the cytokine complex. The researchers hypothesize that this interaction alters the shape of full-length fibrillin-1 and dislodges the inert TGFß. Other enzymes could then activate it.

Fibrillin fragments wouldn't normally be loose in the extracellular matrix, but some fibrillin mutations distort the protein so that it is more likely to be sliced up by ECM enzymes. That might unleash the TGFß-releasing segment, the researchers speculate. Formula



Mitch Leslie

mitchleslie{at}comcast.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Fibrillin-1 regulates the bioavailability of TGFß1
Shazia S. Chaudhry, Stuart A. Cain, Amanda Morgan, Sarah L. Dallas, C. Adrian Shuttleworth, and Cay M. Kielty
J. Cell Biol. 2007 176: 355-367. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 903K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents